187 related articles for article (PubMed ID: 34715144)
1. Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice.
Lalani S; Tan SH; Tan KO; Lim HX; Ong KC; Wong KT; Poh CL
Life Sci; 2021 Dec; 287():120097. PubMed ID: 34715144
[TBL] [Abstract][Full Text] [Related]
2. Molecular Docking of SP40 Peptide towards Cellular Receptors for Enterovirus 71 (EV-A71).
Masomian M; Lalani S; Poh CL
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770987
[TBL] [Abstract][Full Text] [Related]
3. Stability and antiviral activity of SP40 peptide in human serum.
Zarif F; Anasir MI; Koh JX; Chew MF; Poh CL
Virus Res; 2021 Oct; 303():198456. PubMed ID: 34314773
[TBL] [Abstract][Full Text] [Related]
4. Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C.
Fang Y; Wang C; Wang C; Yang R; Bai P; Zhang XY; Kong J; Yin L; Qiu Y; Zhou X
J Virol; 2021 May; 95(12):. PubMed ID: 33789997
[TBL] [Abstract][Full Text] [Related]
5. Drug repurposing of pyrimidine analogs as potent antiviral compounds against human enterovirus A71 infection with potential clinical applications.
Sun J; Yogarajah T; Lee RCH; Kaur P; Inoue M; Tan YW; Chu JJH
Sci Rep; 2020 May; 10(1):8159. PubMed ID: 32424333
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1.
Tan CW; Chan YF; Sim KM; Tan EL; Poh CL
PLoS One; 2012; 7(5):e34589. PubMed ID: 22563456
[TBL] [Abstract][Full Text] [Related]
7. Licochalcone A inhibits enterovirus A71 replication in vitro and in vivo.
Cao Y; Lei E; Wang X; Qi X; Li L; Ren J; Yang J; Wang S
Antiviral Res; 2021 Nov; 195():105091. PubMed ID: 34044060
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of SP81 peptide against Enterovirus A71 (EV-A71).
Abd-Aziz N; Lee MF; Ong SK; Poh CL
Virology; 2024 Jan; 589():109941. PubMed ID: 37984152
[TBL] [Abstract][Full Text] [Related]
9. Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors.
Hsieh CF; Jheng JR; Lin GH; Chen YL; Ho JY; Liu CJ; Hsu KY; Chen YS; Chan YF; Yu HM; Hsieh PW; Chern JH; Horng JT
Emerg Microbes Infect; 2020 Dec; 9(1):1194-1205. PubMed ID: 32397909
[TBL] [Abstract][Full Text] [Related]
10. Sodium Copper Chlorophyllin Is Highly Effective against Enterovirus (EV) A71 Infection by Blocking Its Entry into the Host Cell.
Liu Z; Xia S; Wang X; Lan Q; Li P; Xu W; Wang Q; Lu L; Jiang S
ACS Infect Dis; 2020 May; 6(5):882-890. PubMed ID: 32233455
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of silymarin in comparison with baicalein against EV-A71.
Lalani SS; Anasir MI; Poh CL
BMC Complement Med Ther; 2020 Mar; 20(1):97. PubMed ID: 32293397
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 14S-(2'-chloro-4'-nitrophenoxy)-8R/S,17-epoxy andrographolide as EV-A71 infection inhibitor.
Dai K; Tan JK; Qian W; Lee RCH; Hann Chu JJ; Zhou GC
Biochem Pharmacol; 2021 Dec; 194():114820. PubMed ID: 34748818
[TBL] [Abstract][Full Text] [Related]
13. Discovery of aminothiazole derivatives as novel human enterovirus A71 capsid protein inhibitors.
Xu Z; Tang Q; Xu T; Cai Y; Lei P; Chen Y; Zou W; Dong C; Lan K; Wu S; Zhou HB
Bioorg Chem; 2022 May; 122():105683. PubMed ID: 35278779
[TBL] [Abstract][Full Text] [Related]
14. Identification of dibucaine derivatives as novel potent enterovirus 2C helicase inhibitors: In vitro, in vivo, and combination therapy study.
Tang Q; Xu Z; Jin M; Shu T; Chen Y; Feng L; Zhang Q; Lan K; Wu S; Zhou HB
Eur J Med Chem; 2020 Sep; 202():112310. PubMed ID: 32619885
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71.
Ho JY; Chern JH; Hsieh CF; Liu ST; Liu CJ; Wang YS; Kuo TW; Hsu SJ; Yeh TK; Shih SR; Hsieh PW; Chiu CH; Horng JT
J Antimicrob Chemother; 2016 Jul; 71(7):1922-32. PubMed ID: 27098012
[TBL] [Abstract][Full Text] [Related]
16. Structure-based virtual screening of ROCK1 inhibitors for the discovery of Enterovirus-A71 antivirals.
Qiao R; Tang W; Li J; Li C; Zhao C; Wang X; Li M; Cui Y; Chen Y; Cai G; Wu Q; Zhao X; Wang P
Virology; 2023 Aug; 585():205-214. PubMed ID: 37384967
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Enterovirus A71 by a Novel 2-Phenyl-Benzimidazole Derivative.
Ibba R; Carta A; Madeddu S; Caria P; Serreli G; Piras S; Sestito S; Loddo R; Sanna G
Viruses; 2021 Jan; 13(1):. PubMed ID: 33406781
[TBL] [Abstract][Full Text] [Related]
18. Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice.
Chang J; Li J; Liu X; Liu G; Yang J; Wei W; Zhang W; Yu XF
BMC Microbiol; 2015 Jul; 15():139. PubMed ID: 26169371
[TBL] [Abstract][Full Text] [Related]
19. Vaccine candidates generated by codon and codon pair deoptimization of enterovirus A71 protect against lethal challenge in mice.
Lee MHP; Tan CW; Tee HK; Ong KC; Sam IC; Chan YF
Vaccine; 2021 Mar; 39(12):1708-1720. PubMed ID: 33640144
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of Mulberroside C against enterovirus A71 in vitro and in vivo.
Cao Y; Lei E; Li L; Ren J; He X; Yang J; Wang S
Eur J Pharmacol; 2021 Sep; 906():174204. PubMed ID: 34051220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]